PATENT CLAIM ANALYSIS

Application Number: 16396056
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-09
Patent Classification: ["514", "092000"]

Abstract:
The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Claim (Index 48):
The compound according to  claim 40 , wherein the compound is: or a salt or stereoisomer thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 100.0
- Lexical Diversity: 1.86486
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13884632', '13293166', '13293177', '13293186', '14505255']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7946572010624718
- 35 USC 102 Novelty (BERT): 0.5211163009087706
- Combined Prediction Score: 0.7673031110471017
- Mean Citation Score: 288.9092720000001
- Max Citation Score: 289.5022600000001
- Similarity Product: 176.44420490500812

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test